SIGN UP
LOG IN
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·07/15/2025 17:06:53
Listen to the news
Gainers
- Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares increased by 400.0% to $16.55 during Tuesday's regular session. The company's market cap stands at $5.2 million.
- Longevity Health Holdings (NASDAQ:XAGE) shares moved upwards by 99.62% to $5.28. The market value of their outstanding shares is at $2.6 million.
- Kairos Pharma (AMEX:KAPA) stock rose 65.66% to $1.14. The company's market cap stands at $11.5 million.
- Polyrizon (NASDAQ:PLRZ) shares rose 34.23% to $0.92. The company's market cap stands at $3.6 million.
- Lixte Biotechnology (NASDAQ:LIXT) shares moved upwards by 20.0% to $3.96. The company's market cap stands at $9.2 million.
- SS Innovations (NASDAQ:SSII) stock increased by 18.16% to $5.61. The company's market cap stands at $919.6 million.
Losers
- Rani Therapeutics Hldgs (NASDAQ:RANI) shares fell 38.8% to $0.43 during Tuesday's regular session. The company's market cap stands at $27.4 million.
- MiNK Therapeutics (NASDAQ:INKT) shares decreased by 29.09% to $28.8. The company's market cap stands at $161.8 million.
- Simulations Plus (NASDAQ:SLP) shares decreased by 24.79% to $13.14. The market value of their outstanding shares is at $351.3 million. As per the news, the Q3 earnings report came out yesterday.
- Inspire Veterinary (NASDAQ:IVP) stock decreased by 24.22% to $0.7. The market value of their outstanding shares is at $1.9 million.
- 60 Degrees (NASDAQ:SXTP) stock declined by 18.94% to $1.75. The company's market cap stands at $3.1 million.
- Kyverna Therapeutics (NASDAQ:KYTX) stock declined by 14.23% to $3.77. The company's market cap stands at $189.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.